Nardin Samuel

Nardin Samuel

Auto-generated profile, based on publicly available information

Nardin Samuel

Faculty of Medicine, University of Toronto, Toronto, Canada

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 October 2023 in Movement Disorders
Verified
Journal Article
Open access
NSNardin Samuel
Nardin Samuel
MDMandy Yi Rong Ding
Mandy Yi Rong Ding
CSCAN SARICA
CAN SARICA
GDGhazaleh Darmani
Ghazaleh Darmani
IHIrene E. Harmsen
Irene E. Harmsen
ALAndres M. Lozano
Andres M. Lozano
Objective: Low‐intensity transcranial focused ultrasound (TUS) is a novel method for neuromodulation. We aimed to study the feasibility of stimulating the bilateral primary motor cortices (M1) with accelerated theta‐burst TUS (a‐tbTUS) on neurophysiologic and clinical outcomes in Parkinson's disease (PD).Methods: Patients were randomly assigned to receive active or sham a‐tbTUS for the first visit and the alternate condition on the second visit, at least 10 days apart. a‐tbTUS was administered in three consecutive sonications at 30‐minute intervals. We used an accelerated protocol to produce an additive effect of stimulation. Patients were studied in the OFF‐medication state. Transcranial magnetic stimulation (TMS)‐elicited motor‐evoked potentials (MEPs) were used to assess motor cortical excitability before and after TUS. Clinical outcomes after a‐tbTUS administration were assessed using the Movement Disorder Society Unified Parkinson's Disease Rating Scale (MDS‐UPDRS)‐III.Results: A total of 20 visits were conducted in 10 PD patients. Compared to the baseline, TMS‐elicited MEP amplitudes significantly increased following active but not sham sonication (P = 0.0057). MEP amplitudes were also higher following a‐tbTUS than sham sonication (P = 0.0064). There were no statistically significant changes in MDS‐UPDRS‐III scores with active or sham a‐tbTUS.Conclusions: a‐tbTUS increases motor cortex excitability and is a feasible non‐invasive neuromodulation strategy in PD. Future studies should determine optimal dosing parameters and the durability of neurophysiologic and clinical outcomes in PD patients. © 2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

25 October 2023 in npj Mental Health Research
Verified
Journal Article
Open access
PDF file
LSLeif Simmatis
Leif Simmatis
EREmma E. Russo
Emma E. Russo
JGJoseph Geraci
Joseph Geraci
IHIrene E. Harmsen
Irene E. Harmsen
NSNardin Samuel
Nardin Samuel
Major depressive disorder (MDD) is a prevalent and debilitating psychiatric disease that leads to substantial loss of quality of life. There has been little progress in developing new MDD therapeutics due to a poor understanding of disease heterogeneity and individuals’ responses to treatments. Electroencephalography (EEG) is poised to improve this, owing to the ease of large-scale data collection and the advancement of computational methods to address artifacts. This review summarizes the viability of EEG for developing brain-based biomarkers in MDD. We examine the properties of well-established EEG preprocessing pipelines and consider factors leading to the discovery of sensitive and reliable biomarkers.

5 December 2021 in Cancers
Verified
Journal Article
Open access
PDF file
NSNardin Samuel
Nardin Samuel
AVArtur Vetkas
Artur Vetkas
NSNardin Samuel
Nardin Samuel
CSCAN SARICA
CAN SARICA
ALAaron Loh
Aaron Loh
ALAndres M Lozano
Andres M Lozano
The evaluation and manipulation of structural and functional networks, which has been integral to advancing functional neurosurgery, is beginning to transcend classical subspecialty boundaries. Notably, its application in neuro-oncologic surgery has stimulated an exciting paradigm shift from the traditional localizationist approach, which is lacking in nuance and optimization. This manuscript reviews the existing literature and explores how structural and functional connectivity analyses have been leveraged to revolutionize and individualize pre-operative tumor evaluation and surgical planning. We describe how this novel approach may improve cognitive and neurologic preservation after surgery and attenuate tumor spread. Furthermore, we demonstrate how connectivity analysis combined with neuromodulation techniques can be employed to induce post-operative neuroplasticity and personalize neurorehabilitation. While the landscape of functional neuro-oncology is still evolving and requires further study to encourage more widespread adoption, this functional approach can transform the practice of neuro-oncologic surgery and improve the care and outcomes of patients with intra-axial tumors.

18 March 2025 in Journal of Alzheimer’s Disease
Verified
Journal Article
Open access
LSLeif Er Simmatis
Leif Er Simmatis
EREmma E Russo
Emma E Russo
TSTayo Steininger
Tayo Steininger
HRHaleigh Riddell
Haleigh Riddell
ECEvelyn Chen
Evelyn Chen
NSNardin Samuel
Nardin Samuel
Background: Alzheimer's disease (AD) is a neurodegenerative disorder that profoundly alters brain function and organization. Currently, there is a lack of validated functional biomarkers to aid in diagnosing and classifying AD. Therefore, there is a pressing need for early, accurate, non-invasive, and accessible methods to detect and characterize disease progression. Electroencephalography (EEG) has emerged as a minimally invasive technique to quantify functional changes in neural activity associated with AD. However, challenges such as poor signal-to-noise ratio—particularly for resting-state (rsEEG) recordings—and issues with standardization have hindered its broader application. Objective: To conduct a pilot analysis of our custom automated preprocessing and feature extraction pipeline to identify indicators of AD and correlates of disease progression. Methods: We analyzed data from 36 individuals with AD and 29 healthy participants recorded using a standard 19-channel EEG and features were processed using our custom end-t-end pipeline. Various features encompassing amplitude, power, connectivity, complexity, and microstates were extracted. Unsupervised machine learning (uniform manifold approximation and projection) and supervised learning (random forest classifiers with nested cross-validation) were used to characterize the dataset and identify differences between AD and healthy groups. Results: Our pipeline successfully detected several new and previously established EEG-based measures indicative of AD status and progression, demonstrating strong external validity. Conclusions: Our findings suggest that this automated approach provides a promising initial framework for implementing EEG biomarkers in the AD patient population, paving the way for improved diagnostic and monitoring strategies.

1 April 2018 in World Neurosurgery
Verified
Journal Article
Closed access
NSNardin Samuel
Nardin Samuel
JPJustine Philteos
Justine Philteos
NANaif M. Alotaibi
Naif M. Alotaibi
CAChristopher Ahuja
Christopher Ahuja
Seyed Alireza MansouriSeyed Alireza Mansouri
Seyed Alireza Mansouri
AKAbhaya V. Kulkarni
Abhaya V. Kulkarni

5 January 2022 in BMC Neurology
Verified
Journal Article
Open access
PDF file
MPMichelle Paff
Michelle Paff
NSNardin Samuel
Nardin Samuel
NANoor Alsafwani
Noor Alsafwani
DPDarcia Paul
Darcia Paul
PDPhedias Diamandis
Phedias Diamandis
ALAndres M. Lozano
Andres M. Lozano
Background: Leukoencephalopathy with brain calcifications and cysts (LCC; also known as Labrune syndrome) is a rare genetic microangiopathy caused by biallelic mutations in SNORD118. The mechanisms by which loss-of-function mutations in SNORD118 lead to the phenotype of leukoencephalopathy, calcifications and intracranial cysts is unknown. Case presentation: We present the histopathology of a 36-year-old woman with ataxia and neuroimaging findings of diffuse white matter abnormalities, cerebral calcifications, and parenchymal cysts, in whom the diagnosis of LCC was confirmed with genetic testing. Biopsy of frontal white matter revealed microangiopathy with small vessel occlusion and sclerosis associated with axonal loss within the white matter. Conclusions: These findings support that the white matter changes seen in LCC arise as a consequence of ischemia rather than demyelination.